Picture of Vitrolife AB logo

VITR Vitrolife AB Income Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual income statement for Vitrolife AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,4801,2461,6813,2343,512
Cost of Revenue
Gross Profit9397681,0461,7801,978
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses9928761,2452,6027,101
Operating Profit488370435632-3,589
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes493366460537-3,712
Provision for Income Taxes
Net Income After Taxes384288344394-3,851
Minority Interest
Net Income Before Extraordinary Items
Net Income383287341394-3,851
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income383287341394-3,851
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS3.532.583.623.03-7.68
Dividends per Share